BioWorld

April 30, 2010

View Archived Issues

Well-Timed Wnt Can Speed Bone Healing After Injury

CEO Stepping Down as Celgene Beats Estimates, Plans Growth

Corrections & Clarifications

Affimed Plans to Take Antibodies into Clinic with $26M Series C

Clinic Roundup

Stock Movers

Other News To Note

FDA Clears Provenge; Up Next: Fast Launch, Slow Ramp

Dendreon Corp. made history on Thursday, securing a long sought-after FDA approval for prostate cancer vaccine Provenge (sipuleucel-T). (BioWorld Today) Read More

HCV Specialist Idenix Raising $26.2M in Stock Offering

Today's news in brief

BioWorld

BioWorld briefs for March 27, 2026.

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...